| Ticker: | INMD |
| Current Price: | $13.27 |
| % Daily Change: | 0.61% |
| Volume (1,000s): | 566.07 |
| Average Volume (1,000s): | 821.27 |
| Market Cap (M): | $763.61 |
| 1/2/2024 Price: | $22.22 |
| Change Since Inception: | -40.28% |
Tavor Building
Shaâ ar Yokneam PO Box 533
Yokneam 2069206
Israel
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, Australia, and India, as well as indirectly through distributors in 46 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.